{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:56:41Z","timestamp":1792828601978,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103"],"award-info":[{"award-number":["2012_A103"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2015_A228"],"award-info":[{"award-number":["2015_A228"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.beem.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:52:19Z","timestamp":1555415539000},"page":"101270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic options after surgical failure in Cushing's disease: A critical review"],"prefix":"10.1016","volume":"33","author":[{"given":"German","family":"Rubinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Osswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Ritzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marily","family":"Theodoropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2019.04.004_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2019.04.004_bib2","first-page":"440","article-title":"Diagnosis and management of cushing's syndrome, results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis","volume":"84","author":"Invitti","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11102-015-0649-2","article-title":"Diagnosis of Cushing's disease","volume":"18","author":"Daniel","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2019.04.004_bib4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of cushing's syndrome, an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib5","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1530\/EJE-14-0883","article-title":"Therapy of endocrine disease, Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence","volume":"172","author":"Petersenn","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4158\/EP15922.RA","article-title":"Predictors of biochemical remission and recurrence after surgical and radiation treatments of cushing disease, a systematic review and meta-analysis","volume":"22","author":"Abu Dabrh","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2019.04.004_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-018-0904-4","article-title":"The experience with transsphenoidal surgery and its importance to outcomes","volume":"21","author":"Honegger","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2019.04.004_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11102-018-0893-3","article-title":"Endoscopic vs. microscopic transsphenoidal surgery for Cushing's disease, a systematic review and meta-analysis","volume":"21","author":"Broersen","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2019.04.004_bib9","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome, A consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2018.02.002","article-title":"Prognostic factors of long-term remission after surgical treatment of cushing's disease","volume":"47","author":"Ioachimescu","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2019.04.004_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/EJE-13-0634","article-title":"Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease, Care reality in the Munich Metropolitan Region","volume":"170","author":"Dimopoulou","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing's disease, Predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4158\/EP161380.OR","article-title":"Postsurgical recurrent cushing disease, clinical benefit of early intervention in patients with normal urinary free cortisol","volume":"22","author":"Carroll","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2019.04.004_bib14","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1210\/jc.2016-2799","article-title":"The desmopressin test predicts better than basal cortisol the long-term surgical outcome of cushing's disease","volume":"101","author":"Vassiliadi","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2019.04.004_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000314223","article-title":"Pituitary surgery for Cushing's disease","volume":"92","author":"Buchfelder","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2019.04.004_bib16","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease, Initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2002.01511.x","article-title":"Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission","volume":"56","author":"Rees","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.04.004_bib18","first-page":"1343","article-title":"Basis of persistent and recurrent Cushing disease, an analysis of findings at repeated pituitary surgery","volume":"97","author":"Dickerman","year":"2002","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","article-title":"Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease","volume":"63","author":"Patil","year":"2008","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2019.04.004_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ecl.2018.01.002","article-title":"Outcomes of pituitary radiation for cushing's disease","volume":"47","author":"Ironside","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2019.04.004_bib21","doi-asserted-by":"crossref","first-page":"e425","DOI":"10.1016\/j.wneu.2018.01.057","article-title":"CyberKnife radiosurgery in the multimodal management of patients with cushing disease","volume":"112","author":"Moore","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib22","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2017-01385","article-title":"Stereotactic radiosurgery for cushing disease, results of an international, multicenter study","volume":"102","author":"Mehta","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib23","article-title":"Upfront Gamma Knife radiosurgery for Cushing's disease and acromegaly, A multicenter, international study","volume":"1\u20137","author":"Gupta","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11060-018-2817-5","article-title":"Repeat stereotactic radiosurgery for Cushing's disease, Outcomes of an international, multicenter study","volume":"138","author":"Mehta","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.beem.2019.04.004_bib25","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1016\/j.wneu.2018.05.067","article-title":"Technique of whole-sellar stereotactic radiosurgery for cushing disease, results from a multicenter, international cohort study","volume":"116","author":"Shepard","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib26","doi-asserted-by":"crossref","first-page":"M23","DOI":"10.1530\/EJE-15-0265","article-title":"A\u00a0critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome","volume":"173","author":"Reincke","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib27","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review, Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/EJE-14-0214","article-title":"Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease","volume":"171","author":"O\u00dfwald","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2019.04.004_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ando.2018.01.002","article-title":"Bilateral adrenalectomy in Cushing's disease, Altered long-term quality of life compared to other treatment options","volume":"80","author":"Sarkis","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.beem.2019.04.004_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ecl.2018.01.004","article-title":"Adrenal surgery for cushing's syndrome, an update","volume":"47","author":"Di Dalmazi","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2019.04.004_bib31","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing's disease, Is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EJE-17-0886","article-title":"Hepatic safety of ketoconazole in cushing's syndrome, results of a compassionate use programme in France","volume":"178","author":"Young","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib33","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating cushing's syndrome, a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2265.1991.tb03517.x","article-title":"Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome","volume":"35","author":"Verhelst","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.04.004_bib35","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1530\/EJE-14-1014","article-title":"Therapy of endocrine disease, Steroidogenesis enzyme inhibitors in Cushing's syndrome","volume":"172","author":"Daniel","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-12-0358","article-title":"Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center","volume":"167","author":"Baudry","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A\u00a012-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2019.04.004_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11102-014-0618-1","article-title":"Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease, Results from an open-ended, open-label extension trial","volume":"18","author":"Schopohl","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2019.04.004_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(17)30326-1","article-title":"Efficacy and safety of once-monthly pasireotide in Cushing's disease, A 12 month clinical trial","volume":"6","author":"Lacroix","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/jc.2008-1533","article-title":"The medical treatment of Cushing's disease, Effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery","volume":"94","author":"Pivonello","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1530\/EJE-10-0382","article-title":"Cabergoline monotherapy in the long-term treatment of Cushing's disease","volume":"163","author":"Godbout","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-16-0662","article-title":"Cabergoline for Cushing's disease, A large retrospective multicenter study","volume":"176","author":"Ferriere","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-15-0807","article-title":"Limited value of cabergoline in Cushing's disease, A prospective study of a 6-week treatment in 20 patients","volume":"174","author":"Burman","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib44","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s40618-018-0936-7","article-title":"Effect of cabergoline monotherapy in Cushing's disease, an individual participant data meta-analysis","volume":"41","author":"Palui","year":"2018","journal-title":"J\u00a0Endocrinol Investig"},{"issue":"3","key":"10.1016\/j.beem.2019.04.004_bib45","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/jc.2018-02080","article-title":"Tumor-directed therapeutic targets in Cushing disease","volume":"104","author":"Theodoropoulou","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib46","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib47","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/EJE-18-0062","article-title":"Management of endocrine disease, can we cure Cushing's disease? A personal view","volume":"178","author":"Bertagna","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.04.004_bib48","first-page":"37","article-title":"Early repeat surgery for persistent Cushing's disease","volume":"80","author":"Ram","year":"1994","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib49","first-page":"31","article-title":"Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease","volume":"65","author":"Knappe","year":"1996","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.beem.2019.04.004_bib50","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/jc.2004-2436","article-title":"Clinical review, the strategy of immediate reoperation for transsphenoidal surgery for Cushing's disease","volume":"90","author":"Locatelli","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.04.004_bib51","first-page":"9","article-title":"Long-term results after microsurgery for Cushing disease, Experience with 426 primary operations over 35 years","volume":"108","author":"Hofmann","year":"2008","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2008.03334.x","article-title":"Repeated transsphenoidal pituitary surgery (TS) via the endoscopic technique, A good therapeutic option for recurrent or persistent Cushing's disease (CD)","volume":"70","author":"Wagenmakers","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.04.004_bib53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2011.04268.x","article-title":"Contemporary microsurgical concept for the treatment of Cushing's disease, Endocrine outcome in 83 consecutive patients","volume":"76","author":"Honegger","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.04.004_bib54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11102-012-0455-z","article-title":"Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation, A large single center experience","volume":"16","author":"Hameed","year":"2013","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2019.04.004_bib55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.endonu.2013.10.008","article-title":"Results of repeated transsphenoidal surgery in Cushing's disease. Long-term follow-up","volume":"61","author":"Valderr\u00e1bano","year":"2014","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.beem.2019.04.004_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1227\/NEU.0000000000001011","article-title":"Outcome of transsphenoidal surgery for cushing disease, a single-center experience over 32 years","volume":"78","author":"Chandler","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2019.04.004_bib57","article-title":"Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease, Implications for immediate reoperation and remission","volume":"1\u201310","author":"Mayberg","year":"2017","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib58","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4158\/EP171756.OR","article-title":"Long-term outcome of the different treatment alternatives for recurrent and persistent Cushing disease","volume":"23","author":"Espinosa-de-Los-Monteros","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2019.04.004_bib59","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.wneu.2018.07.055","article-title":"Outcome of transsphenoidal surgery for cushing disease, a single-center experience over 20 years","volume":"119","author":"Brichard","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1227\/00006123-198708000-00015","article-title":"Long term results of transsphenoidal adenomectomy in patients with Cushing's disease","volume":"21","author":"Nakane","year":"1987","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2019.04.004_bib61","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1227\/01.NEU.0000215945.26764.92","article-title":"Surgical treatment of recurrent Cushing's disease","volume":"58","author":"Hofmann","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2019.04.004_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.wneu.2015.11.046","article-title":"Outcome of microscopic transsphenoidal surgery in cushing disease, a case series of 96 patients","volume":"87","author":"Shirvani","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib63","first-page":"520","article-title":"Repeat transsphenoidal surgery for Cushing's disease","volume":"71","author":"Friedman","year":"1989","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.beem.2019.04.004_bib64","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2001.01261.x","article-title":"Transsphenoidal pituitary surgery in Cushing's disease, Can we predict outcome?","volume":"54","author":"Chee","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.04.004_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00006123-200207000-00008","article-title":"Transsphenoidal surgery for Cushing's disease, Endocrinological follow-up monitoring of 82 patients","volume":"51","author":"Shimon","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.beem.2019.04.004_bib66","first-page":"1004","article-title":"Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma","volume":"102","author":"Benveniste","year":"2005","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.beem.2019.04.004_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10143-013-0506-6","article-title":"Early promising results for the endoscopic surgical treatment of Cushing's disease","volume":"37","author":"Berker","year":"2014","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.beem.2019.04.004_bib68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/a-0580-0460","article-title":"Cushing's syndrome, a historic review of the treatment strategies and corresponding outcomes in a single tertiary center over the past half-century","volume":"50","author":"Nankova","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2019.04.004_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","article-title":"Osilodrostat, a potent oral 11\u03b2-hydroxylase inhibitor, 22-week, prospective, Phase II study in Cushing's disease","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19300132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:54:56Z","timestamp":1761497696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X19300132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1521690X19300132"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2019.04.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic options after surgical failure in Cushing's disease: A critical review","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101270"}}